Biblio

Author Title [ Type

] Year

Filters: Author is Xu, Ming [Clear All Filters]

Journal Article

Ning X, Du Y, Ben Q, Huang L, He X, Gong Y, Gao J, Wu H, Man X, Jin J, et al. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and two compounds can target these CSCs. Cell Cycle. 2015.

Zhang Z, Wang T, Xu M, Zhang Z, Wang H, Xue J, Wang W. Deciphering the Pancreatic Cancer Microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on Tumor Progression and Prognostic Significance. Pharmacol Res. 2024:107197.

Li J, Xiong M, Fu X-H, Fan Y, Dong C, Sun X, Zheng F, Wang S-W, Liu L, Xu M, et al. Determining a multimodal aging clock in a cohort of Chinese women. Med. 2023.

Xu M, Liu X, Zhou X, Qin Y, Yang L, Wen S, Qiu Y, Chen S, Tang R, Guo Y, et al. Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation. Pharmacol Res. 2023:106964.

Huang L, Wu Y, Xu M, Wang Y, Jia C, Song G, Song K, Wu Y, Zhang Y. Psychological Effects of a Structured Exercise Intervention During Umbilical Cord Blood Transplantation in Children and Adolescents. Integr Cancer Ther. 2023;22:15347354231210857.

Xu L, Xu M, Sun X, Feliu N, Feng L, Parak WJ, Liu S. Quantitative Comparison of Gold Nanoparticle Delivery the Enhanced Permeation and Retention (EPR) Effect and Mesenchymal Stem Cell (MSC)-Based Targeting. ACS Nano. 2023.

Shi H, Han L, Zhao J, Wang K, Xu M, Shi J, Dong Z. Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma. Cancer Med. 2021.

Chang Y, Chen L, Tang J, Chen G, Ji J, Xu M. USP7-mediated JUND suppresses RCAN2 transcription and elevates NFATC1 to enhance stem cell property in colorectal cancer. Cell Biol Toxicol. 2023.